ANKL is a rare and aggressive type of blood cancer affecting a type of white blood cell called natural killer (NK) cells. In ANKL, the NK cells are abnormal and multiply out of control, crowding out ...
Aggressive NK-cell leukemia (ANKL) results from the systemic neoplastic proliferation of natural killer (NK) cells. ANKL shows an aggressive clinical course with features that overlap with the ...
Perseus Proteomics, Inc. ( (JP:4882)) has shared an announcement. Perseus Proteomics, Inc. has announced an extension of the Phase I/II clinical trial period for its anti-transferrin receptor 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results